These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


292 related items for PubMed ID: 18757914

  • 1. LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE*3Leiden mice: time course and mechanisms.
    Verschuren L, de Vries-van der Weij J, Zadelaar S, Kleemann R, Kooistra T.
    J Lipid Res; 2009 Feb; 50(2):301-11. PubMed ID: 18757914
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
    Yan W, Zhang T, Cheng J, Zhou X, Qu X, Hu H.
    Pharmacology; 2010 Feb; 86(5-6):306-12. PubMed ID: 21071998
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Liver X receptor activation attenuates plaque formation and improves vasomotor function of the aortic artery in atherosclerotic ApoE(-/-) mice.
    Chen J, Zhao L, Sun D, Narsinh K, Li C, Zhang Z, Qi S, Wei G, Li W, Guo W, Cao F.
    Inflamm Res; 2012 Dec; 61(12):1299-307. PubMed ID: 22833121
    [Abstract] [Full Text] [Related]

  • 7. Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits.
    Honzumi S, Shima A, Hiroshima A, Koieyama T, Terasaka N.
    Biochim Biophys Acta; 2011 Dec; 1811(12):1136-45. PubMed ID: 21875689
    [Abstract] [Full Text] [Related]

  • 8. Group X secretory phospholipase A2 negatively regulates ABCA1 and ABCG1 expression and cholesterol efflux in macrophages.
    Shridas P, Bailey WM, Gizard F, Oslund RC, Gelb MH, Bruemmer D, Webb NR.
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):2014-21. PubMed ID: 20844270
    [Abstract] [Full Text] [Related]

  • 9. Tissue-specific autoregulation of the LXRalpha gene facilitates induction of apoE in mouse adipose tissue.
    Ulven SM, Dalen KT, Gustafsson JA, Nebb HI.
    J Lipid Res; 2004 Nov; 45(11):2052-62. PubMed ID: 15292368
    [Abstract] [Full Text] [Related]

  • 10. Ligand, receptor, and cell type-dependent regulation of ABCA1 and ABCG1 mRNA in prostate cancer epithelial cells.
    Trasino SE, Kim YS, Wang TT.
    Mol Cancer Ther; 2009 Jul; 8(7):1934-45. PubMed ID: 19531574
    [Abstract] [Full Text] [Related]

  • 11. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes.
    Laffitte BA, Repa JJ, Joseph SB, Wilpitz DC, Kast HR, Mangelsdorf DJ, Tontonoz P.
    Proc Natl Acad Sci U S A; 2001 Jan 16; 98(2):507-12. PubMed ID: 11149950
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological activation of LXR in utero directly influences ABC transporter expression and function in mice but does not affect adult cholesterol metabolism.
    van Straten EM, Huijkman NC, Baller JF, Kuipers F, Plösch T.
    Am J Physiol Endocrinol Metab; 2008 Dec 16; 295(6):E1341-8. PubMed ID: 18840761
    [Abstract] [Full Text] [Related]

  • 13. Differential regulation of ABCA1 and ABCG1 gene expressions in the remodeling mouse hippocampus after entorhinal cortex lesion and liver-X receptor agonist treatment.
    Jasmin SB, Pearson V, Lalonde D, Domenger D, Théroux L, Poirier J.
    Brain Res; 2014 May 08; 1562():39-51. PubMed ID: 24661912
    [Abstract] [Full Text] [Related]

  • 14. LXR/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells.
    Murthy S, Born E, Mathur SN, Field FJ.
    J Lipid Res; 2002 Jul 08; 43(7):1054-64. PubMed ID: 12091489
    [Abstract] [Full Text] [Related]

  • 15. Unsaturated fatty acids repress expression of ATP binding cassette transporter A1 and G1 in RAW 264.7 macrophages.
    Ku CS, Park Y, Coleman SL, Lee J.
    J Nutr Biochem; 2012 Oct 08; 23(10):1271-6. PubMed ID: 22209005
    [Abstract] [Full Text] [Related]

  • 16. Liver X receptor and retinoic X receptor agonists modulate the expression of genes involved in lipid metabolism in human endothelial cells.
    Norata GD, Ongari M, Uboldi P, Pellegatta F, Catapano AL.
    Int J Mol Med; 2005 Oct 08; 16(4):717-22. PubMed ID: 16142410
    [Abstract] [Full Text] [Related]

  • 17. Homocysteine accelerates atherosclerosis via inhibiting LXRα-mediated ABCA1/ABCG1-dependent cholesterol efflux from macrophages.
    Jin P, Bian Y, Wang K, Cong G, Yan R, Sha Y, Ma X, Zhou J, Yuan Z, Jia S.
    Life Sci; 2018 Dec 01; 214():41-50. PubMed ID: 30393020
    [Abstract] [Full Text] [Related]

  • 18. T0901317 is a dual LXR/FXR agonist.
    Houck KA, Borchert KM, Hepler CD, Thomas JS, Bramlett KS, Michael LF, Burris TP.
    Mol Genet Metab; 2004 Dec 01; 83(1-2):184-7. PubMed ID: 15464433
    [Abstract] [Full Text] [Related]

  • 19. Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8.
    Yu L, York J, von Bergmann K, Lutjohann D, Cohen JC, Hobbs HH.
    J Biol Chem; 2003 May 02; 278(18):15565-70. PubMed ID: 12601003
    [Abstract] [Full Text] [Related]

  • 20. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions.
    Marleau S, Harb D, Bujold K, Avallone R, Iken K, Wang Y, Demers A, Sirois MG, Febbraio M, Silverstein RL, Tremblay A, Ong H.
    FASEB J; 2005 Nov 02; 19(13):1869-71. PubMed ID: 16123174
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.